Iodinated contrast agents for angiography in chronic kidney disease (CKD) patients could further deteriorate their renal function leading to adverse sequelae. The use of carbon dioxide (CO2) is reported in the literature and has been safely used for a variety of angiographic procedures, particularly to guide aortic and renal interventions. We report the case of the successful endovascular treatment with a covered stent of a right external iliac artery pseudoaneurysm following graft nephrectomy in a CKD patient, using CO2 as contrast medium
OBJECTIVES:Compare the use of carbon dioxide contrast medium with iodine contrast medium for the end...
Objectives CO2-EVAR was proposed for treatment of AAA especially in patients with CKD. Issues regar...
AbstractIn patients with renal insufficiency or hypersensitivity to iodinated contrast material, car...
Iodinated contrast agents for angiography in chronic kidney disease (CKD) patients could further det...
ObjectiveRenal dysfunction following endovascular abdominal aortic aneurysm repair (EVAR) remains a ...
To assess feasibility, efficacy and safety of carbon dioxide (CO2) digital subtraction angiography (...
ObjectiveAvoidance of nephrotoxic contrast agents during endovascular repair of abdominal aortic ane...
AbstractAllergic reactions to contrast media, preexisting renal dysfunction, and hyperthyroidism are...
Recent literature shows how residual renal function (RKF), defined as the urinary clearance of urea ...
ObjectiveThis report analyzes the safety and efficacy of carbon dioxide digital subtraction angiogra...
ABSTRACTBackground: Renal artery stenosis (RAS) is the most common cause of secondary hypertension.S...
none9noBackground: Endovascular aortic repair (EVAR) is presently the preferred treatment for abdomi...
none9noBackground: Contrast-induced nephropathy is a possible adverse event in fenestrated endovascu...
Contrast angiography with carbon dioxide (CO2) is frequently used in patients with renal dysfunction...
Chronic kidney disease is a common comorbidity in patients with peripheral artery disease. We invest...
OBJECTIVES:Compare the use of carbon dioxide contrast medium with iodine contrast medium for the end...
Objectives CO2-EVAR was proposed for treatment of AAA especially in patients with CKD. Issues regar...
AbstractIn patients with renal insufficiency or hypersensitivity to iodinated contrast material, car...
Iodinated contrast agents for angiography in chronic kidney disease (CKD) patients could further det...
ObjectiveRenal dysfunction following endovascular abdominal aortic aneurysm repair (EVAR) remains a ...
To assess feasibility, efficacy and safety of carbon dioxide (CO2) digital subtraction angiography (...
ObjectiveAvoidance of nephrotoxic contrast agents during endovascular repair of abdominal aortic ane...
AbstractAllergic reactions to contrast media, preexisting renal dysfunction, and hyperthyroidism are...
Recent literature shows how residual renal function (RKF), defined as the urinary clearance of urea ...
ObjectiveThis report analyzes the safety and efficacy of carbon dioxide digital subtraction angiogra...
ABSTRACTBackground: Renal artery stenosis (RAS) is the most common cause of secondary hypertension.S...
none9noBackground: Endovascular aortic repair (EVAR) is presently the preferred treatment for abdomi...
none9noBackground: Contrast-induced nephropathy is a possible adverse event in fenestrated endovascu...
Contrast angiography with carbon dioxide (CO2) is frequently used in patients with renal dysfunction...
Chronic kidney disease is a common comorbidity in patients with peripheral artery disease. We invest...
OBJECTIVES:Compare the use of carbon dioxide contrast medium with iodine contrast medium for the end...
Objectives CO2-EVAR was proposed for treatment of AAA especially in patients with CKD. Issues regar...
AbstractIn patients with renal insufficiency or hypersensitivity to iodinated contrast material, car...